Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 4;14(7):e081148.
doi: 10.1136/bmjopen-2023-081148.

Bronchoscopy with and without needle-based confocal laser endomicroscopy for peripheral lung nodule diagnosis: protocol for a multicentre randomised controlled trial (CLEVER trial)

Affiliations

Bronchoscopy with and without needle-based confocal laser endomicroscopy for peripheral lung nodule diagnosis: protocol for a multicentre randomised controlled trial (CLEVER trial)

Saskia van Heumen et al. BMJ Open. .

Abstract

Introduction: Despite many technological advances, the diagnostic yield of bronchoscopic peripheral lung nodule analysis remains limited due to frequent mispositioning. Needle-based confocal laser endomicroscopy (nCLE) enables real-time microscopic feedback on needle positioning, potentially improving the sampling location and diagnostic yield. Previous studies have defined and validated nCLE criteria for malignancy, airway and lung parenchyma. Larger studies demonstrating the effect of nCLE on diagnostic yield are lacking. We aim to investigate if nCLE-imaging integrated with conventional bronchoscopy results in a higher diagnostic yield compared with conventional bronchoscopy without nCLE.

Methods and analysis: This is a parallel-group randomised controlled trial. Recruitment is performed at pulmonology outpatient clinics in universities and general hospitals in six different European countries and one hospital in the USA. Consecutive patients with a for malignancy suspected peripheral lung nodule (10-30 mm) with an indication for diagnostic bronchoscopy will be screened, and 208 patients will be included. Web-based randomisation (1:1) between the two procedures will be performed. The primary outcome is diagnostic yield. Secondary outcomes include diagnostic sensitivity for malignancy, needle repositionings, procedure and fluoroscopy duration, and complications. Pathologists will be blinded to procedure type; patients and endoscopists will not.

Ethics and dissemination: Primary approval by the Ethics Committee of the Amsterdam University Medical Center. Dissemination involves publication in a peer-reviewed journal.

Support: Financial and material support from Mauna Kea Technologies.

Trial registration number: NCT06079970.

Keywords: Biopsy; Clinical Trial; Cytopathology; Diagnostic Imaging; Respiratory tract tumours.

PubMed Disclaimer

Conflict of interest statement

Competing interests: JTA declares material and financial support to the sponsor’s institution from Mauna Kea Technologies for this study. All Cellvizio equipment needed for the conduct of the study is provided in-kind to participating centers. All other authors declare no other conflicts of interest.

Figures

Figure 1
Figure 1
Study flow chart. EMN, electromagnetic navigation; nCLE, neelde-based confocal laser endomicroscopy; PET, positron emission tomography; r-EBUS, radial endobronchial ultrasound; TBNA, transbronchial needle aspiration; VB, virtual bronchoscopy.
Figure 2
Figure 2
Procedure flow chart for control and intervention group (without and with nCLE). Fluorescein administration is only done once before the first puncture. EBUS, radial endobronchial ultrasound; EMN, electromagnetic navigation; nCLE, neelde-based confocal laser endomicroscopy; PET, positron emission tomography; ROSE, rapid on-site evaluation; TBNA, transbronchial needle aspiration; VB, virtual bronchoscopy.
Figure 3
Figure 3
Flow chart explaining calculation methods of diagnostic yield and sensitivity of malignancy. FN, false negative; ND, non-diagnostic; NSB, non-specific benign; SPB, specific benign; TN, true negative; TP, true positive.

References

    1. Bade BC, Dela Cruz CS. Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med 2020;41:1–24. 10.1016/j.ccm.2019.10.001 - DOI - PubMed
    1. Sung H, Ferlay J, Siegel RL, et al. . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209–49. 10.3322/caac.21660 - DOI - PubMed
    1. Hoffman RM, Atallah RP, Struble RD, et al. . Lung cancer screening with low-dose CT: a meta-analysis. J Gen Intern Med 2020;35:3015–25. 10.1007/s11606-020-05951-7 - DOI - PMC - PubMed
    1. Hyldgaard C, Trolle C, Harders SMW, et al. . Increased use of diagnostic CT imaging increases the detection of stage IA lung cancer: pathways and patient characteristics. BMC Cancer 2022;22:464. 10.1186/s12885-022-09585-2 - DOI - PMC - PubMed
    1. Zhang EW, Shepard J-AO, Kuo A, et al. . Characteristics and outcomes of lung cancers detected on low-dose lung cancer screening CT. Cancer Epidemiol Biomarkers Prev 2021;30:1472–9. 10.1158/1055-9965.EPI-20-1847 - DOI - PubMed

Publication types

MeSH terms

Associated data